Measuring daily movement and sitting in adults with type 2 diabetes
Measures daily activity and sitting time in adults living with type 2 diabetes.
Plain-language title generated from the registry record
Registry title: Movement Behaviours Among Bahraini Diabetics
Key facts
- Where
- Building 10, Road 43, Building 2009, Road 2641, Building 2858, Road 1653, and Building 6347, Road Nakheel Street, BahrainSee the 4 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for Bahraini men and women with well-controlled type 2 diabetes. They will wear an accelerometer device for seven days to measure how much they move.
- Age
- 20 to 75 years
- Sex
- Men and women can join.
- Disease stage
- Type 2 diabetes that is under control: HbA1c <9 on medication. Blood pressure under 160/100 mmHg. Fasting triglycerides under 600 mg.
- Earlier treatment
- People taking insulin cannot join.
- Biomarker or test result
- HbA1c <9 on medication, from the last routine visit within four months, or measured at the first visit.
Main reasons for not taking part
- HbA1c above 9% (75 mmol/mol)
- Type 1 diabetes
- Taking insulin
- Pregnancy
- Cannot stand or move around because of a medical condition
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 75 years old?
Source: NCT06069258, who can take part
Where in Bahrain
- Isa Town Health CentreBuilding 10, Road 43, BahrainContact: Ebrahim Rajab, PhDTaking people
- Ahmed Ali Kanoo Health CentreBuilding 2009, Road 2641, BahrainContact: Ebrahim Rajab, PhDTaking people
- Halat Bu Maher Health CentreBuilding 2858, Road 1653, BahrainContact: Ebrahim Rajab, PhDNot yet recruiting
- Shaikh Jaber AlSabah Health CentreBuilding 6347, Road Nakheel Street, BahrainContact: Ebrahim Rajab, PhDNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Royal College of Surgeons in Ireland - Medical University of Bahrain
- Trial code
- NCT06069258
- Record updated
- 26 February 2025
- Original description
This observational study aims to measure movement behaviours and explore factors influencing these among Bahraini patients with type 2 diabetes.Read full original descriptionShow less
Movement Behaviours Among Bahraini Type 2 Diabetic Adults: a Cross-sectional Study
This observational study aims to measure movement behaviours and explore factors influencing these among Bahraini patients with type 2 diabetes.
The main objectives are:
(i) Measure free-living physical activity and sedentary behaviour with an accelerometer device (ii) Examine associations between movement behaviours and anthropometric and diabetes-related biochemical/clinical parameters (iii) Examine associations between movement behaviours and psychological and environmental determinants that influence movement behaviours (iv) Assess the feasibility and acceptability of the physical activity assessment tools as part of routine clinical practice with clinicians and diabetic patients
Participants will be invited to wear an accelerometer device for seven days.
Inclusion: Sex: Men and women are eligible; Age: Individuals aged 20-75 years old are eligible; Ethnicity: Bahraini adults of all ethnic groups are eligible for the study; Type 2 diabetes and glycaemic control: Individuals with controlled type 2 diabetes (i.e. HbA1c <9 on medication) based on the medical record of each patient's last visit to the health centre for routine follow-up will be eligible if within the last four months. Otherwise, these measurements will be ordered at the first visit to confirm eligibility; Blood pressure: Individuals whose blood pressure is under moderate control will be eligible - specifically, treated or untreated resting systolic/diastolic pressure < 160/100 mmHg; Lipid control: Individuals with fasting triglyceride concentration < 600 mg are eligible.
Exclusion: Type 1 diabetes; Non-ambulant or severely incapacitated with any medical condition(s) reducing ability to stand or mobilize; HbA1c >9%; Taking insulin; Pregnancy; Currently participating in a study to reduce sedentary behaviour or increase physical activity; Language. Inability to read and understand Arabic or English language; Inability to give informed consent.